X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
triple therapy (197) 197
index medicus (181) 181
humans (158) 158
cardiac & cardiovascular systems (156) 156
percutaneous coronary intervention (145) 145
atrial fibrillation (144) 144
aspirin (115) 115
dual antiplatelet therapy (111) 111
clopidogrel (96) 96
anticoagulants (92) 92
warfarin (91) 91
oral anticoagulation (86) 86
myocardial-infarction (79) 79
drug therapy, combination (71) 71
triple antithrombotic therapy (68) 68
antithrombotic therapy (67) 67
male (64) 64
female (62) 62
aged (56) 56
antiplatelet therapy (56) 56
atrial-fibrillation (55) 55
cardiology (54) 54
stents (53) 53
cardiac patients (51) 51
stroke (50) 50
acute myocardial-infarction (49) 49
platelet aggregation inhibitors - therapeutic use (49) 49
treatment outcome (49) 49
management (48) 48
risk (48) 48
risk factors (47) 47
atrial fibrillation - drug therapy (46) 46
hemorrhage - chemically induced (45) 45
acute coronary syndrome (44) 44
anticoagulants - administration & dosage (44) 44
care and treatment (44) 44
platelet aggregation inhibitors - administration & dosage (44) 44
intervention (43) 43
anticoagulants - adverse effects (42) 42
middle aged (42) 42
platelet aggregation inhibitors - adverse effects (42) 42
acute coronary syndromes (41) 41
bleeding (41) 41
coronary heart disease (40) 40
anticoagulants - therapeutic use (39) 39
eluting stent implantation (39) 39
anticoagulation (38) 38
european-society (38) 38
cardiovascular (37) 37
pharmacology & pharmacy (37) 37
administration, oral (36) 36
consensus document (36) 36
stent implantation (36) 36
thrombosis (36) 36
ticlopidine - analogs & derivatives (36) 36
prevention (35) 35
transluminal angioplasty (35) 35
abridged index medicus (34) 34
atrial fibrillation - complications (34) 34
drug-eluting stents (34) 34
medicine & public health (32) 32
coronary artery disease (31) 31
myocardial infarction (30) 30
stent (28) 28
peripheral vascular disease (27) 27
rivaroxaban (27) 27
heart attacks (26) 26
medicine, general & internal (26) 26
time factors (26) 26
drug therapy (25) 25
therapy (25) 25
thromboembolism (25) 25
aspirin - therapeutic use (24) 24
dabigatran (24) 24
fibrinolytic agents - therapeutic use (24) 24
percutaneous coronary intervention - adverse effects (24) 24
cardiac arrhythmia (23) 23
analysis (22) 22
artery-disease (22) 22
elevation myocardial-infarction (22) 22
fibrinolytic agents - administration & dosage (22) 22
acute coronary syndrome - drug therapy (21) 21
association task-force (21) 21
dosage and administration (21) 21
fibrinolytic agents - adverse effects (21) 21
mortality (21) 21
stroke - prevention & control (21) 21
ticlopidine - therapeutic use (21) 21
aspirin - administration & dosage (20) 20
atrial-fibrillation patients (20) 20
fibrillation (20) 20
hematology (20) 20
medical research (20) 20
patients (20) 20
cardiovascular disease (19) 19
focused update (19) 19
hemorrhage (19) 19
oral anticoagulant (19) 19
task-force (19) 19
antiplatelet (18) 18
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (292) 292
German (4) 4
Portuguese (3) 3
Russian (3) 3
Polish (2) 2
Spanish (2) 2
Czech (1) 1
Dutch (1) 1
Japanese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 10/2017, Volume 377, Issue 16, pp. 1513 - 1524
In this trial, dabigatran plus a P2Y 12 inhibitor was compared with warfarin plus a P2Y 12 inhibitor and aspirin after PCI in patients with atrial... 
MEDICINE, GENERAL & INTERNAL | PERCUTANEOUS CORONARY INTERVENTION | HEART-DISEASE | MYOCARDIAL-INFARCTION | ORAL ANTICOAGULATION | 2011 ACCF/AHA/SCAI GUIDELINE | AMERICAN-COLLEGE | ASSOCIATION TASK-FORCE | TRIPLE THERAPY | ANTIPLATELET THERAPY | CONSENSUS DOCUMENT | Dabigatran - adverse effects | Ticlopidine - therapeutic use | Humans | Middle Aged | Warfarin - adverse effects | Male | Risk | Dabigatran - therapeutic use | Incidence | Warfarin - therapeutic use | Purinergic P2Y Receptor Antagonists - adverse effects | Drug Therapy, Combination - adverse effects | Adenosine - adverse effects | Adenosine - therapeutic use | Female | Aspirin - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Ticagrelor | Purinergic P2Y Receptor Antagonists - therapeutic use | Hemorrhage - epidemiology | Atrial Fibrillation - drug therapy | Atrial Fibrillation - therapy | Anticoagulants - therapeutic use | Anticoagulants - adverse effects | Ticlopidine - analogs & derivatives | Adenosine - analogs & derivatives | Clopidogrel | Aged | Hemorrhage - chemically induced | Percutaneous Coronary Intervention | Warfarin | Atrial fibrillation | Dosage and administration | Research | Thromboembolism | Hemorrhage | Health aspects | Myocardial infarction | Cerebral infarction | Cardiac arrhythmia | Anticoagulants | Aspirin | Stroke | Embolisms | Preventive medicine | Thrombosis | Bleeding | Embolism | Fibrillation | Cardiology | Drug therapy | Drug dosages | Geriatrics | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Journal Article
Journal Article
Annals of internal medicine, ISSN 0003-4819, 11/2014, Volume 161, Issue 10, pp. 690 - 698
Journal Article
Journal Article
European Heart Journal, ISSN 0195-668X, 05/2018, Volume 39, Issue 19, pp. 1726 - 1735a
Abstract Aims Of patients with atrial fibrillation (AF), approximately 10% undergo percutaneous coronary intervention (PCI). We studied the safety and efficacy... 
Dual therapy | Percutaneous coronary intervention | Antithrombotic therapy | Triple therapy | Atrial fibrillation | Meta-Analysis
Journal Article
American Journal of Medicine, The, ISSN 0002-9343, 2017, Volume 130, Issue 11, pp. 1280 - 1289
Journal Article
Journal Article